Ehrlichiosis y anaplasmosis, revisión de tema sobre una enfermedad atípica emergente en humanos

Resumen

Introducción: La ehrlichiosis humana y la anaplasmosis son enfermedades febriles agudas transmitidas por garrapatas causadas por varios miembros de los géneros Ehrlichia y Anaplasma. Las infecciones emergentes con nuevas especies de Ehrlichia y Anaplasma se han diagnosticado con más frecuencia en humanos, ya que los reservorios animales y los vectores de garrapatas han aumentado en número y la presencia de poblaciones humanas habitando áreas donde se encuentran reservorios de estas ello favorece su transmisibilidad. Revision de tema: La ehrlichiosis monocitotrópica humana (HME) y la anaplasmosis granulocítica humana (HGA) tienen presentaciones clínicas similares, que incluyen fiebre, dolor de cabeza, anomalías hematológicas (p. ej., leucopenia y trombocitopenia) y enzimas hepáticas elevadas. Las manifestaciones neurológicas se informan con mayor frecuencia con HME. Al igual que otras enfermedades infecciosas, el cultivo de Ehrlichia y Anaplasma es el estándar de oro en el diagnóstico de HME y HGA. Sin embargo, el aislamiento primario puede demorar varias semanas. Se sugiere un diagnóstico mediante la visualización de mórulas intracitoplasmáticas en neutrófilos en pacientes que residen o viajan a un área endémica. El tratamiento básicamente está basado en el uso de la doxiciclina.

 Discusion y Conclusiones: La descripcion de este tipo de infecciones puede pasar desapercibido en pacientes con cuadros que pueden ser infra valorados o comportarse como una simuladora de otros procesos infecciosos. La prevencion es la medida fundamental para evitar la aparicion de cuadros por este tipo de germenes intracelulares.

Palabras clave: infección, inmunidad, vectores, fiebre

Descargas

La descarga de datos todavía no está disponible.

Citas

Alcantara, V. E., Gallardo, E. G., Hong, C., & Walker, D. H. (2004). Typhus Group Rickettsiae Antibodies in Rural Mexico. Emerging Infectious Diseases, 10(3), 549–551. https://doi.org/10.3201/eid1003.030438

Bakken, J. S. (1994). Human Granulocytic Ehrlichiosis in the Upper Midwest United States. JAMA, 272(3), 212. https://doi.org/10.1001/jama.1994.03520030054028

Bakken, J. S. (1996). Clinical and laboratory characteristics of human granulocytic ehrlichiosis. JAMA: The Journal of the American Medical Association, 275(3), 199–205. https://doi.org/10.1001/jama.275.3.199

Bakken, J. S., & Dumler, J. S. (2006). Clinical Diagnosis and Treatment of Human Granulocytotropic Anaplasmosis. Annals of the New York Academy of Sciences, 1078(1), 236–247. https://doi.org/10.1196/annals.1374.042

Bakken, J. S., Goellner, P., van Etten, M., Boyle, D. Z., Swonger, O. L., Mattson, S., Dumler, J. S. (1998). Seroprevalence of Human Granulocytic Ehrlichiosis Among Permanent Residents of Northwestern Wisconsin. Clinical Infectious Diseases, 27(6), 1491–1492. https://doi.org/10.1086/515048

Biggs, H. M., Behravesh, C. B., Bradley, K. K., Dahlgren, F. S., Drexler, N. A., Dumler, J. S., . . . Traeger, M. S. (2016). Diagnosis and Management of Tickborne Rickettsial Diseases: Rocky Mountain Spotted Fever and Other Spotted Fever Group Rickettsioses, Ehrlichioses, and Anaplasmosis — United States. MMWR. Recommendations and Reports, 65(2), 1–44. https://doi.org/10.15585/mmwr.rr6502a1

Bitsaktsis, C., Huntington, J., & Winslow, G. (2004). Production of IFN-γ by CD4 T Cells Is Essential for Resolving Ehrlichia Infection. The Journal of Immunology, 172(11), 6894–6901. https://doi.org/10.4049/jimmunol.172.11.6894

Bouwman, L. I., de Zoete, M. R., Bleumink-Pluym, N. M. C., Flavell, R. A., & van Putten, J. P. M. (2014). Inflammasome Activation by Campylobacter jejuni. The Journal of Immunology, 193(9), 4548–4557. https://doi.org/10.4049/jimmunol.1400648

Brayton, K. A., Palmer, G. H., & Brown, W. C. (2006). Genomic and proteomic approaches to vaccine candidate identification forAnaplasma marginale. Expert Review of Vaccines, 5(1), 95–101. https://doi.org/10.1586/14760584.5.1.95

Buller, R. S., Arens, M., Hmiel, S. P., Paddock, C. D., Sumner, J. W., Rikihisa, Y., . . . Storch, G. A. (1999). Ehrlichia ewingii, a Newly Recognized Agent of Human Ehrlichiosis. New England Journal of Medicine, 341(3), 148–155. https://doi.org/10.1056/nejm199907153410303

Case, C. L., Kohler, L. J., Lima, J. B., Strowig, T., de Zoete, M. R., Flavell, R. A., . . . Roy, C. R. (2013). Caspase-11 stimulates rapid flagellin-independent pyroptosis in response to Legionella pneumophila. Proceedings of the National Academy of Sciences, 110(5), 1851–1856. https://doi.org/10.1073/pnas.1211521110

Castillo, C. G., Eremeeva, M. E., Paskewitz, S. M., Sloan, L. M., Lee, X., Irwin, W. E., . . . Pritt, B. S. (2015). Detection of human pathogenic Ehrlichia muris-like agent in Peromyscus leucopus. Ticks and Tick-borne Diseases, 6(2), 155–157. https://doi.org/10.1016/j.ttbdis.2014.11.006

Chan, K., Marras, S. A., & Parveen, N. (2013). Sensitive multiplex PCR assay to differentiate Lyme spirochetes and emerging pathogens Anaplasma phagocytophilum and Babesia microti. BMC Microbiology, 13(1). https://doi.org/10.1186/1471-2180-13-295

Cheng, C., Nair, A. D. S., Indukuri, V. V., Gong, S., Felsheim, R. F., Jaworski, D., . . . Ganta, R. R. (2013). Targeted and Random Mutagenesis of Ehrlichia chaffeensis for the Identification of Genes Required for In vivo Infection. PLoS Pathogens, 9(2), e1003171. https://doi.org/10.1371/journal.ppat.1003171

Cheng, Z., Kumagai, Y., Lin, M., Zhang, C., & Rikihisa, Y. (2006). Intra-leukocyte expression of two-component systems in Ehrlichia chaffeensis and Anaplasma phagocytophilum and effects of the histidine kinase inhibitor closantel. Cellular Microbiology, 8(8), 1241–1252. https://doi.org/10.1111/j.1462-5822.2006.00704.x

Demma, L. J., Mcquiston, J. H., Krebs, J. W., Swerdlow, D. L., & Holman, R. C. (2005). Epidemiology Of Human Ehrlichiosis And Anaplasmosis In The United States, 2001–2002. The American Journal of Tropical Medicine and Hygiene, 73(2), 400–409. https://doi.org/10.4269/ajtmh.2005.73.400

Deretic, V., Saitoh, T., & Akira, S. (2013). Autophagy in infection, inflammation and immunity. Nature Reviews Immunology, 13(10), 722–737. https://doi.org/10.1038/nri3532

Doyle, C. K., Labruna, M. B., Breitschwerdt, E. B., Tang, Y. W., Corstvet, R. E., Hegarty, B. C., . . . McBride, J. W. (2005). Detection of Medically Important Ehrlichia by Quantitative Multicolor TaqMan Real-Time Polymerase Chain Reaction of the dsb Gene. The Journal of Molecular Diagnostics, 7(4), 504–510. https://doi.org/10.1016/s1525-1578(10)60581-8

Dumler, J. S. (2005). Anaplasma and Ehrlichia Infection. Annals of the New York Academy of Sciences, 1063(1), 361–373. https://doi.org/10.1196/annals.1355.069

Dumler, J. S., Barbet, A. F., Bekker, C. P., Dasch, G. A., Palmer, G. H., Ray, S. C., . . . Rurangirwa, F. R. (2001). Reorganization of genera in the families Rickettsiaceae and Anaplasmataceae in the order Rickettsiales: unification of some species of Ehrlichia with Anaplasma, Cowdria with Ehrlichia and Ehrlichia with Neorickettsia, descriptions of six new species combinations and designation of Ehrlichia equi and «HGE agent» as subjective synonyms of Ehrlichia phagocytophila. International Journal of Systematic and Evolutionary Microbiology, 51(6), 2145–2165. https://doi.org/10.1099/00207713-51-6-2145

Dunning Hotopp, J. C., Lin, M., Madupu, R., Crabtree, J., Angiuoli, S. V., Eisen, J., . . . Tettelin, H. (2006). Comparative Genomics of Emerging Human Ehrlichiosis Agents. PLoS Genetics, 2(2), e21. https://doi.org/10.1371/journal.pgen.0020021

Felek, S., Huang, H., & Rikihisa, Y. (2003). Sequence and Expression Analysis of virB9 of the Type IV Secretion System of Ehrlichia canis Strains in Ticks, Dogs, and Cultured Cells. Infection and Immunity, 71(10), 6063–6067. https://doi.org/10.1128/iai.71.10.6063-6067.2003

Galvão, M. A. M., Dumler, J. S., Mafra, C. L., Calic, S. B., Chamone, C. B., Filho, G. C., . . . Walker, D. H. (2003). Fatal Spotted Fever Rickettsiosis, Minas Gerais, Brazil. Emerging Infectious Diseases, 9(11), 1402–1405. https://doi.org/10.3201/eid0911.030193

Hongo, I., & Bloch, K. C. (2006). Ehrlichia infection of the central nervous system. Current Treatment Options in Neurology, 8(3), 179–184. https://doi.org/10.1007/s11940-006-0008-8

Kanneganti, T. D. (2010). Central roles of NLRs and inflammasomes in viral infection. Nature Reviews Immunology, 10(10), 688–698. https://doi.org/10.1038/nri2851

Kocianová, E., Košt’anová, Z., ŠTefanidesová, K., ŠPitalská, E., Boldiš, V., Hučková, D., & Stanek, G. (2008). Serologic evidence of Anaplasma phagocytophilum infections in patients with a history of tick bite in central Slovakia. Wiener klinische Wochenschrift, 120(13–14), 427–431. https://doi.org/10.1007/s00508-008-1000-y

Luo, T., Zhang, X., Nicholson, W. L., Zhu, B., & McBride, J. W. (2010). Molecular Characterization of Antibody Epitopes of Ehrlichia chaffeensis Ankyrin Protein 200 and Tandem Repeat Protein 47 and Evaluation of Synthetic Immunodeterminants for Serodiagnosis of Human Monocytotropic Ehrlichiosis. Clinical and Vaccine Immunology, 17(1), 87–97. https://doi.org/10.1128/cvi.00331-09

Lupfer, C., & Kanneganti, T. D. (2013). The expanding role of NLRs in antiviral immunity. Immunological Reviews, 255(1), 13–24. https://doi.org/10.1111/imr.12089

Olano, J. P., Hogrefe, W., Seaton, B., & Walker, D. H. (2003). Clinical Manifestations, Epidemiology, and Laboratory Diagnosis of Human Monocytotropic Ehrlichiosis in a Commercial Laboratory Setting. Clinical and Vaccine Immunology, 10(5), 891–896. https://doi.org/10.1128/cdli.10.5.891-896.2003

Paddock, C., Folk, S., Shore, G., Machado, L., Huycke, M., Slater, L., . . . Childs, J. (2001). Infections withEhrlichia chaffeensisandEhrlichia ewingiiin Persons Coinfected with Human Immunodeficiency Virus. Clinical Infectious Diseases, 33(9), 1586–1594. https://doi.org/10.1086/323981

Pritt, B. S., Sloan, L. M., Johnson, D. K. H., Munderloh, U. G., Paskewitz, S. M., McElroy, K. M., . . . Eremeeva, M. E. (2011). Emergence of a New Pathogenic Ehrlichia Species, Wisconsin and Minnesota, 2009. New England Journal of Medicine, 365(5), 422–429. https://doi.org/10.1056/nejmoa1010493

Rikihisa, Y. (2010). Molecular events involved in cellular invasion by Ehrlichia chaffeensis and Anaplasma phagocytophilum. Veterinary Parasitology, 167(2–4), 155–166. https://doi.org/10.1016/j.vetpar.2009.09.017

Saito, T. B., Thirumalapura, N. R., Shelite, T. R., Rockx-Brouwer, D., Popov, V. L., & Walker, D. H. (2014). An Animal Model of a Newly Emerging Human Ehrlichiosis. Journal of Infectious Diseases, 211(3), 452–461. https://doi.org/10.1093/infdis/jiu372

Saito, T. B., & Walker, D. H. (2015). A Tick Vector Transmission Model of Monocytotropic Ehrlichiosis. Journal of Infectious Diseases, 212(6), 968–977. https://doi.org/10.1093/infdis/jiv134Schutze, G. E., Buckingham, S. C., Marshall, G. S., Woods, C. R., Jackson, M. A., Patterson, L. E., & Jacobs, R. F. (2007). Human Monocytic Ehrlichiosis in Children. Pediatric Infectious Disease Journal, 26(6), 475–479. https://doi.org/10.1097/inf.0b013e318042b66c

Unver, A., Rikihisa, Y., Karaman, M., & Ozen, H. (2009). An acute severe ehrlichiosis in a dog experimentally infected with a new virulent strain of Ehrlichia canis. Clinical Microbiology and Infection, 15, 59–61. https://doi.org/10.1111/j.1469-0691.2008.02634.x

Wang, X., Shaw, D. K., Hammond, H. L., Sutterwala, F. S., Rayamajhi, M., Shirey, K. A., . . . Pedra, J. H. F. (2016). The Prostaglandin E2-EP3 Receptor Axis Regulates Anaplasma phagocytophilum-Mediated NLRC4 Inflammasome Activation. PLOS Pathogens, 12(8), e1005803. https://doi.org/10.1371/journal.ppat.1005803

Wormser, G. P., Dattwyler, R. J., Shapiro, E. D., Halperin, J. J., Steere, A. C., Klempner, M. S., . . . Nadelman, R. B. (2006). The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America. Clinical Infectious Diseases, 43(9), 1089–1134. https://doi.org/10.1086/508667

Yang, Q., Stevenson, H. L., Scott, M. J., & Ismail, N. (2015). Type I Interferon Contributes to Noncanonical Inflammasome Activation, Mediates Immunopathology, and Impairs Protective Immunity during Fatal Infection with Lipopolysaccharide-Negative Ehrlichiae. The American Journal of Pathology, 185(2), 446–461. https://doi.org/10.1016/j.ajpath.2014.10.005

Zhang, J. Z., Popov, V. L., Gao, S., Walker, D. H., & Yu, X. J. (2007). The developmental cycle of Ehrlichia chaffeensis in vertebrate cells. Cellular Microbiology, 9(3), 610–618. https://doi.org/10.1111/j.1462-5822.2006.00812.x

Publicado
2022-06-15
Cómo citar
Theran León , J. S., Dulcey Sarmiento, L. A., Saenz Sandoval, E., Jaimes Martinez, E. M., Gutiérrez Gómez, E. A., Ordoñez Llanes, K., & Gil Sierra, D. J. (2022). Ehrlichiosis y anaplasmosis, revisión de tema sobre una enfermedad atípica emergente en humanos. Ciencia Latina Revista Científica Multidisciplinar, 6(3), 2067-2083. https://doi.org/10.37811/cl_rcm.v6i3.2358
Sección
Artículos

Artículos más leídos del mismo autor/a